Elliotts B by is a Prescription medication manufactured, distributed, or labeled by QOL Medical, LLC. Drug facts, warnings, and ingredients follow.
Elliotts B® Solution is a sterile, nonpyrogenic, isotonic solution containing no bacteriostatic preservatives. Elliotts B Solution is a diluent for intrathecal administration of methotrexate sodium and cytarabine.
Each 10 mL of Elliotts B Solution contains:
Sodium Chloride, USP | 73 mg |
Sodium Bicarbonate, USP | 19 mg |
Dextrose, USP | 8 mg |
Magnesium Sulfate 7H2O, USP | 3 mg |
Potassium Chloride, USP | 3 mg |
Calcium Chloride 2H2O, USP | 2 mg |
Sodium Phosphate, dibasic 7H2O, USP | 2 mg |
Water for Injection, USP | qs 10 mL |
Sodium | 149 mEq/liter | Bicarbonate | 22.6 mEq/liter |
Potassium | 4.0 mEq/liter | Chloride | 132 mEq/liter |
Calcium | 2.7 mEq/liter | Sulfate | 2.4 mEq/liter |
Magnesium | 2.4 mEq/liter | Phosphate | 1.5 mEq/liter |
The formulae and molecular weights of the ingredients are:
INGREDIENT | MOLECULAR FORMULA | MOLECULAR WEIGHT |
Sodium Chloride | NaCl | 58.44 |
Sodium Bicarbonate | NaHCO3
| 84.01 |
Dextrose | C6H12O6
| 180.16 |
Magnesium Sulfate 7H2O | Mg2SO4 7H2O | 246.48 |
Potassium Chloride | KCl | 74.55 |
Calcium Chloride 2H2O | CaCl2 2H2O | 147.01 |
Sodium Phosphate, dibasic 7H2O | Na2HPO4 7H2O | 268.07 |
Elliotts B Solution provides a buffered salt solution for use as a diluent for the intrathecal administration of methotrexate sodium and cytarabine. It has been demonstrated that Elliotts B Solution is comparable to cerebrospinal fluid in pH, electrolyte composition, glucose content, and osmolarity:
Comparison of Electrolyte Composition, pH and Nonelectrolytic Constituents of Elliotts B Solution and CSF
Solution |
Na+
|
K+
|
Ca++
|
Mg++
|
HCO3-
|
Cl-
|
pH |
Phosphorus |
Glucose |
Cerebrospinal Fluid |
117-137 |
2.3-4.6 |
2.2 |
2.2 |
22.9 |
113-127 |
7.31 |
1.2-2.1 |
45-80 |
Elliotts B Solution |
149 |
4.0 |
2.7 |
2.4 |
22.6 |
132 |
6.0-7.5 |
2.3 |
80 |
The approximate buffer capacity of Elliotts B Solution is 1.1 X 10-2 equivalents when the challenge solution is 0.01 N HCl and 7.8 X 10-3 equivalents when the challenge solution is 0.01 N NaOH.1
Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by personnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents. The labeling for methotrexate sodium and cytarabine should be consulted.
Particular attention should be taken to assure the maintenance of sterile technique throughout the procedure. (See DOSAGE AND ADMINISTRATION.)
Adverse reactions may occur with any given intrathecal injection due to the chemotherapy or the technique of intrathecal administration. (See product labeling for methotrexate sodium and cytarabine.)
Preservative-free methotrexate sodium and cytarabine should be used to minimize adverse reactions due to preservatives.
If an adverse reaction does occur, discontinue the administration, evaluate the patient, institute appropriate therapeutic countermeasures and, if possible, save the remainder of the unused solution(s) for examination.
See product labeling for methotrexate sodium and cytarabine.
Elliotts B Solution is intended for intrathecal administration only. Elliotts B Solution does not contain antibacterial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences. Therefore, administration of intrathecal solutions should be accomplished as soon as possible after preparation.
A sterile filter-needle should be used to withdraw the contents of the ampule.
Intrathecal drug products should be inspected visually for particulate matter and discoloration prior to administration.
Elliotts B Solution is a diluent for the cytotoxic anticancer agents, methotrexate sodium and cytarabine. Care should be exercised in the handling and preparation of infusion solutions with these products. (See product labeling for methotrexate sodium and cytarabine.)
NDC | SIZE |
67871-007-10 | 10 mL ampule |
ELLIOTTS B
sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate injection |
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
Labeler - QOL Medical, LLC (140026258) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ELLIOTTS B 86281243 4687545 Live/Registered |
Lukare Medical, LLC 2014-05-14 |
ELLIOTTS B 74620305 2101832 Dead/Cancelled |
Orphan Medical, Inc. 1995-01-11 |